Altimmune, Inc.
ALT
$5.61
-$0.36-6.03%
| 12/31/2024 | 09/30/2024 | 06/30/2024 | 03/31/2024 | 12/31/2023 | |
|---|---|---|---|---|---|
| Net Income | 26.74% | -10.52% | -53.42% | -21.52% | -46.08% |
| Total Depreciation and Amortization | -71.05% | 106.70% | 112.08% | -14.40% | -75.32% |
| Total Amortization of Deferred Charges | -- | -- | -- | -- | -- |
| Total Other Non-Cash Items | -82.94% | -22.93% | 24.06% | 22.93% | 904.46% |
| Change in Net Operating Assets | 200.12% | -224.39% | 157.50% | 421.60% | -66.91% |
| Cash from Operations | -10.48% | -32.37% | 6.58% | 15.72% | 4.47% |
| Capital Expenditure | -- | -- | -- | -- | 100.00% |
| Sale of Property, Plant, and Equipment | -- | -- | -- | -- | -- |
| Cash Acquisitions | -- | -- | -- | -- | -- |
| Divestitures | -- | -- | -- | -- | -- |
| Other Investing Activities | 271.28% | -72.76% | -192.79% | -395.97% | -881.06% |
| Cash from Investing | 271.28% | -72.76% | -192.70% | -397.11% | -911.31% |
| Total Debt Issued | -- | -- | -- | -- | -- |
| Total Debt Repaid | -- | -- | -- | -- | -- |
| Issuance of Common Stock | -86.14% | -54.24% | -98.52% | 72.96% | 88,669.51% |
| Repurchase of Common Stock | 94.59% | -100.00% | 51.20% | -23.71% | 70.40% |
| Issuance of Preferred Stock | -- | -- | -- | -- | -- |
| Repurchase of Preferred Stock | -- | -- | -- | -- | -- |
| Total Dividends Paid | -- | -- | -- | -- | -- |
| Other Financing Activities | -- | -- | -- | -- | -- |
| Cash from Financing | -86.14% | -54.76% | -100.35% | 13.58% | 169,295.35% |
| Foreign Exchange rate Adjustments | -- | -- | -- | -- | -- |
| Miscellaneous Cash Flow Adjustments | -- | -- | -- | -- | -- |
| Net Change in Cash | -88.70% | -65.54% | -837.37% | -776.21% | 394.86% |
